List of Omeros (company) patents

Patents where

Current Assignee

Name

Omeros (company)

Name	Description	Patent Applicant	Current Assignee	Patent Jurisdiction	Patent Number	Date of Patent
‌ US Patent 11464785 Treatment of addiction and impulse-control disorders using PDE7 inhibitors		Omeros (company)	Omeros (company)	United States Patent and Trademark Office	11464785	October 11, 2022
‌ US Patent 7067144 Compositions and methods for systemic inhibition of cartilage degradation	Patent 7067144 was granted and assigned to Omeros (company) on June, 2006 by the United States Patent and Trademark Office.		Omeros (company)	United States Patent and Trademark Office	7067144	June 27, 2006
‌ US Patent 11045544 Methods of generating bioactive peptide-bearing antibodies and compositions comprising the same	Patent 11045544 was granted and assigned to Omeros (company) on June, 2021 by the United States Patent and Trademark Office.	Omeros (company)	Omeros (company)	United States Patent and Trademark Office	11045544	June 29, 2021
‌ US Patent 9777065 Anti-FZD10 monoclonal antibodies and methods for their use	Patent 9777065 was granted and assigned to Omeros (company) on October, 2017 by the United States Patent and Trademark Office.	Omeros (company)	Omeros (company)	United States Patent and Trademark Office	9777065	October 3, 2017
‌ US Patent 9585895 Ophthalmologic irrigation solutions and method	Patent 9585895 was granted and assigned to Omeros (company) on March, 2017 by the United States Patent and Trademark Office.	Omeros (company)	Omeros (company)	United States Patent and Trademark Office	9585895	March 7, 2017
‌ US Patent 9278101 Ophthalmologic irrigation solutions and method	Patent 9278101 was granted and assigned to Omeros (company) on March, 2016 by the United States Patent and Trademark Office.	Omeros (company)	Omeros (company)	United States Patent and Trademark Office	9278101	March 8, 2016
‌ US Patent 9399040 Ophthalmologic irrigation solutions and method	Patent 9399040 was granted and assigned to Omeros (company) on July, 2016 by the United States Patent and Trademark Office.	Omeros (company)	Omeros (company)	United States Patent and Trademark Office	9399040	July 26, 2016
‌ US Patent 9815876 Chimeric inhibitor molecules of complement activation	Patent 9815876 was granted and assigned to Omeros (company) on November, 2017 by the United States Patent and Trademark Office.		Omeros (company)	United States Patent and Trademark Office	9815876	November 14, 2017
‌ US Patent 9475885 Compositions for inhibiting MASP-2 dependent complement activation	Patent 9475885 was granted and assigned to Omeros (company) on October, 2016 by the United States Patent and Trademark Office.	Omeros (company)	Omeros (company)	United States Patent and Trademark Office	9475885	October 25, 2016
‌ US Patent 9011860 Compositions for inhibiting MASP-2 dependent complement activation	Patent 9011860 was granted and assigned to Omeros (company) on April, 2015 by the United States Patent and Trademark Office.		Omeros (company)	United States Patent and Trademark Office	9011860	April 21, 2015
‌ US Patent 11661418 MASP-2 inhibitors and methods of use	Patent 11661418 was granted and assigned to Omeros (company) on May, 2023 by the United States Patent and Trademark Office.	Omeros (company)	Omeros (company)	United States Patent and Trademark Office	11661418	May 30, 2023
‌ US Patent 9066856 Stable preservative-free mydriatic and anti-inflammatory solutions for injection	Patent 9066856 was granted and assigned to Omeros (company) on June, 2015 by the United States Patent and Trademark Office.	Omeros (company)	Omeros (company)	United States Patent and Trademark Office	9066856	June 30, 2015
‌ US Patent 11628217 Highly concentrated low viscosity MASP-2 inhibitory antibody formulations, kits, and methods	Patent 11628217 was granted and assigned to Omeros (company) on April, 2023 by the United States Patent and Trademark Office.	Omeros (company)	Omeros (company)	United States Patent and Trademark Office	11628217	April 18, 2023
‌ US Patent 9855246 Stable preservative-free mydriatic and anti-inflammatory solutions for injection	Patent 9855246 was granted and assigned to Omeros (company) on January, 2018 by the United States Patent and Trademark Office.	Omeros (company)	Omeros (company)	United States Patent and Trademark Office	9855246	January 2, 2018
‌ US Patent 9486406 Stable preservative-free mydriatic and anti-inflammatory solutions for injection	Patent 9486406 was granted and assigned to Omeros (company) on November, 2016 by the United States Patent and Trademark Office.	Omeros (company)	Omeros (company)	United States Patent and Trademark Office	9486406	November 8, 2016
‌ US Patent 8999654 Method of identifying a compound for the treatment or prevention of obesity	Patent 8999654 was granted and assigned to Omeros (company) on April, 2015 by the United States Patent and Trademark Office.		Omeros (company)	United States Patent and Trademark Office	8999654	April 7, 2015
‌ US Patent 10292374 G protein coupled receptor 85 and SREB3 knockout mice and uses thereof	Patent 10292374 was granted and assigned to Omeros (company) on May, 2019 by the United States Patent and Trademark Office.	Omeros (company)	Omeros (company)	United States Patent and Trademark Office	10292374	May 21, 2019
‌ US Patent 11584714 MASP-2 inhibitors and methods of use	Patent 11584714 was granted and assigned to Omeros (company) on February, 2023 by the United States Patent and Trademark Office.	Omeros (company)	Omeros (company)	United States Patent and Trademark Office	11584714	February 21, 2023
‌ US Patent 9650368 Processes and intermediates for the preparation of a PDE10 inhibitor	Patent 9650368 was granted and assigned to Omeros (company) on May, 2017 by the United States Patent and Trademark Office.	Omeros (company)	Omeros (company)	United States Patent and Trademark Office	9650368	May 16, 2017
‌ US Patent 9346888 Generation of anti-FN14 monoclonal antibodies by ex-vivo accelerated antibody evolution	Patent 9346888 was granted and assigned to Omeros (company) on May, 2016 by the United States Patent and Trademark Office.	Omeros (company)	Omeros (company)	United States Patent and Trademark Office	9346888	May 24, 2016
‌ US Patent 10047165 Compositions for inhibiting MASP-2 dependent complement activation	Patent 10047165 was granted and assigned to Omeros (company) on August, 2018 by the United States Patent and Trademark Office.	Omeros (company)	Omeros (company)	United States Patent and Trademark Office	10047165	August 14, 2018
‌ US Patent 9434707 PDE10 inhibitors and related compositions and methods	Patent 9434707 was granted and assigned to Omeros (company) on September, 2016 by the United States Patent and Trademark Office.	Omeros (company)	Omeros (company)	United States Patent and Trademark Office	9434707	September 6, 2016
‌ US Patent 9855256 Cyclooxygenase inhibitor and calcium channel antagonist compositions and methods for use in urological procedures	Patent 9855256 was granted and assigned to Omeros (company) on January, 2018 by the United States Patent and Trademark Office.	Omeros (company)	Omeros (company)	United States Patent and Trademark Office	9855256	January 2, 2018
‌ US Patent 9850238 Optically active PDE10 inhibitor	Patent 9850238 was granted and assigned to Omeros (company) on December, 2017 by the United States Patent and Trademark Office.	Omeros (company)	Omeros (company)	United States Patent and Trademark Office	9850238	December 26, 2017
‌ US Patent 10106516 PDE10 inhibitors and related compositions and methods	Patent 10106516 was granted and assigned to Omeros (company) on October, 2018 by the United States Patent and Trademark Office.	Omeros (company)	Omeros (company)	United States Patent and Trademark Office	10106516	October 23, 2018

Results per page:

50 results

0 selected

50 results

0 selected